Efficacy of intravenous granisetron versus placebo in the prophylaxis of postoperative nausea and vomiting after infratentorial craniotomy: A double-blind randomised study

Egyptian Journal of Anaesthesia

Volumn 19, Issue 3, 2003, Pages 297-304

  El Shobaki, Adel M ^a   Bondok, Rasha S ^a   Yakoub, Ayman M ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Granisetron; Infratentorial craniotomy; Postoperative nausea and vomiting

Indexed keywords

ANTIEMETIC AGENT; GRANISETRON; METOCLOPRAMIDE; PLACEBO; SEROTONIN 3 ANTAGONIST; SODIUM CHLORIDE;

ADULT; AGE; AGED; ANESTHESIOLOGICAL TECHNIQUES; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONFUSION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRANIOTOMY; DETERIORATION; DIARRHEA; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG USE; DURA MATER; ELECTIVE SURGERY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; INCIDENCE; MALE; PAIN ASSESSMENT; POSTOPERATIVE ANALGESIA; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PERIOD; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEDATION; STANDARD; STATISTICAL SIGNIFICANCE; VERTIGO;

EID: 0242331293     PISSN: 11101849     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Watcha MF, Whit PF: Postoperative nausea and vomiting: Its etiology, treatment, and prevention. Anesthesiology 1992;77:162-184.
2. Fabling JM, Gan TJ, Guy J, et al: Postoperative nausea and vomiting: A retrospective analysis in patients undergoing elective craniotomy. J Neurosurg Anesthesiol 1997;9:308-312.
3. Fabling M, Gan TJ, El-Moalem HE, et al: A randomized, double-blind comparison of ondansetron versus placebo for prevention of nausea and vomiting after infratentorial craniotomy. J Neurosurg Anesthesiol 2002;14:102-107.
4. Scarantine CW, Ornitz RD, Hoffman LG, et al: On the mechanism of radiation-induced emesis: The role of serotonin. Int J Radiat Oncol Biol Phys 1994;30:825-830.
5. Van Wijngaarden I, Tulp MT, Soudijn W, et al: The concept of selectivity in 5-HT receptor research. Fur J Pharm 1990;188:301-312.
6. Halperin R, Murphy B: Extrapyramidal reaction to ondansetron. Cancer 1992;96:1275.
7. Yarker YE, McTavish D: Granisetron: an update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy. Drugs 1994;48:769-793.
8. Fujii Y, Toyooka H, Tanaka H: Prevention of postoperative nausea and vomiting with a combination of granisetron and droperidol. Anesth Analg 1998;86:613-616.
9. Fujii Y, Toyooka H, Tanaka H: Granisetron reduces the incidence of nausea and vomiting after middle ear surgery. Br J Anaesth 1997;79:539-540.
10. Ramsay MA, Savage TM, Simpson BR, Goodwin R: Controlled sedation with alphaxalone-alphadolone. BMJ 1974;2:656-659.
11. Manninen PH, Raman SK, Boyle K, et al: Early postoperative complications following neurosurgical procedures. Can J Anaesth 1999;46:7-14.
12. Furst SR, Sullivan LJ, Soriano SG, et al: Effects of ondansetron on emesis in the first 24 hours after craniotomy in children. Anesth Analg 1996;83:325-328.
13. Andrews PLR, Bhandari P, Davey PT, et al: Are all 5-HT3 receptor antagonists the same? Eur J Cancer 1992;28:S2-S6.
14. Newberry NR, Watkins CJ, Sprosen TS, et al: BRL 46470 potently antagonizes neural responses activated by 5-HT3 receptors. Neuropharmacology 1993;32:729-735.
15. Elliott P, Seemungal BM, Wallis DI: Antagonism of the effects of 5-hydroxytryptamine on the rabbit isolated vagus nerve by BRL 43694 and metoclopramide. Naunyn Schmiedebergs Arch Pharmacol 1990;341:503-509.
16. Marr HE, Davey PT, Bartlett AJ: Emerging differences between 5-HT3 receptor antagonists. Anticancer Drugs 1991;2:513-518.
17. Madenoglu H, Yilidiz K, Dogru K, et al: Randomized double blinded comparison of tropisetron and placebo for prevention of postoperative nausea and vomiting after supra-tentorial craniotomy. J Neurosurg Anesthesiol 2003;15:82-86.
18. Sinha PK, Tripathi M, Ambesh SP: Efficacy of ondansetron in prophylaxis of postoperative nausea and vomiting in patients following infratentorial surgery: A placebo-controlled, prospective double-blind study. J Neurosurg Anesthesiol 1999;11:6-10.
19. Fujii Y, Tanaka H, Toyooka H: Granisetron reduces the incidence and severity of nausea and vomiting after laparoscopic cholecystectomy. Can J Anaesth 1997;44:396-400.
20. Bermudez J, Boyle EA, Miner WD, Sanger GJ: The anti-emetic potential of the 5-hydroxytryptamine 3 receptor antagonist BRL 43694. Br J Cancer 1988; 58:644-650.
21. Kathirvel S, Dash HH, Bhatia A, et al: Effect of prophylactic ondansetron on postoperative nausea and vomiting after elective craniotomy. J Neurosurg Anesthesiol 2001;13:207-212.
22. Dupre LJ, Stieglitz P: Extrapyramidal reactions to low dose droperidol in children. Br J Anaesth 1980; 52:831-833.
23. Allen JC, Gralla RJ, Reilley C, et al: Metoclopramide: Dose related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy. J Clin Oncol 1985;3:1136-1141.
24. Riviere A: Dose finding study of granisetron in patients receiving high-dose cisplatin chemotherapy. The Granisetron Study Group. Br J Cancer 1994;69: 967-971.
25. Perez EA, Navari RM, Kaplan HG et al: Efficacy and safety of different doses of granisetron for the prophylaxis of cisplatin-induced emesis. Support Care Cancer 1997;5:31-37.
26. Navari RM, Kaplan HG, Gralla RJ, et al: Efficacy and safety of granisetron, a selective 5 hydroxy-tryptamine-3 receptor antagonist, in the prevention of nausea and vomiting induced by high-dose cisplatin. J Clin Oncol 1994;12:2204-2210.
27. Tasch MD: Corticosteroids and anesthesia. Curr Opin Anesthesiol 2002;15:377-381.
28. Mckenzie R, Tantisira B, Karambelkar DJ, et al: Comparison of ondansetron with ondansetron plus dexamethasone in the prevention of postoperative nausea and vomiting. Anesth Analg 1994;79:961-964.